دورية أكاديمية
Efficacy and Safety of Primary Stereotactic Radiosurgery in Patients With Intraventricular Meningiomas
العنوان: | Efficacy and Safety of Primary Stereotactic Radiosurgery in Patients With Intraventricular Meningiomas |
---|---|
المؤلفون: | Sebastian M. Christ, MD, PhD, Dara S. Farhadi, MS, Sun Junzhao, MD, Anand Mahadevan, MD, Maximilian Thormann, MD, Fred C. Lam, MD, PhD, Xin Yu, MD, PhD, Ekkehard M. Kasper, MD, PhD |
المصدر: | Advances in Radiation Oncology, Vol 8, Iss 1, Pp 101098- (2023) |
بيانات النشر: | Elsevier, 2023. |
سنة النشر: | 2023 |
المجموعة: | LCC:Medical physics. Medical radiology. Nuclear medicine LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
مصطلحات موضوعية: | Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
الوصف: | Purpose: Primary stereotactic radiosurgery for intraventricular meningiomas remains controversial owing to the potential for life-threatening peritumoral edema and lack of long-term follow-up data. We review the literature and present the largest series to assess efficacy and safety of primary stereotactic radiosurgery. Methods and Materials: A systematic review of the literature for primary stereotactic radiosurgery for intraventricular meningiomas was conducted. The retrospective series presented here comprised 33 patients who received primary stereotactic radiosurgery between 1999 and 2015 for a radiologically detected intraventricular meningioma. Demographic, diagnostic, and therapeutic data were extracted from medical records, imaging, and treatment-planning systems. Both standalone and pooled analysis were performed. Results: The mean patient age was 53 years, and 24 patients (73%) were female. The median Karnofsky performance status pretreatment was 80 (range, 60-100). The majority of lesions were located in the lateral ventricles (n = 32; 97%). The mean tumor volume was 8.7 cm3 (range, 0.6-44.55 cm3). The mean delivered dose was 1390.9 cGy. Complete imaging follow-up data were available for 21 patients (64%). Of those, 14 (67%) showed partial or marginal response, 7 (33%) had stable disease, and no patient progressed per Response Assessment in Neuro-Oncology criteria. On last follow-up, 32 patients (97%) had significant improvement in performance status and a decrease in pretreatment symptoms. No high-grade Common Terminology Criteria for Adverse Events (version 5.0) toxicity was observed with the dose range employed. Conclusions: Primary stereotactic radiosurgery for intraventricular meningiomas shows excellent treatment efficacy and low toxicity in patients with a long follow-up period. The best therapeutic algorithm remains to be established leveraging further clinical investigation. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 2452-1094 |
Relation: | http://www.sciencedirect.com/science/article/pii/S2452109422002044; https://doaj.org/toc/2452-1094 |
DOI: | 10.1016/j.adro.2022.101098 |
URL الوصول: | https://doaj.org/article/790407e2da7d426bb258bc04e5e18103 |
رقم الأكسشن: | edsdoj.790407e2da7d426bb258bc04e5e18103 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 24521094 |
---|---|
DOI: | 10.1016/j.adro.2022.101098 |